The Anti-CD47 (Magrolimab) Biosimilar mAb (HDBS0001) is a cutting-edge monoclonal antibody designed for research involving CD47, a cell surface protein known for its role in immune evasion and cancer progression. This biosimilar antibody, highly specific to human CD47, is raised in a state-of-the-art facility and validated for use in a variety of applications, including flow cytometry and immunohistochemistry.CD47, a transmembrane protein dubbed the "don't eat me" signal, is a key player in immune checkpoint pathways, allowing cancer cells to evade detection and destruction by the immune system. Targeting CD47 has emerged as a promising strategy for cancer immunotherapy, with potential applications in a wide range of malignancies.
This biosimilar mAb offers researchers a powerful tool to study the mechanisms of CD47-mediated immune evasion and develop novel therapeutic approaches for cancer treatment.With its high specificity and proven efficacy in detecting CD47 in human samples, the Anti-CD47 (Magrolimab) Biosimilar mAb (HDBS0001) is an essential reagent for laboratories engaged in cancer research, immunotherapy development, and the exploration of immune checkpoint inhibitors. By facilitating the study of CD47 biology and its implications in cancer immunology, this biosimilar mAb opens up new avenues for advancing our understanding of tumor immune evasion mechanisms and improving the efficacy of cancer therapies.
Product Name:
Magrolimab (Anti-CD47) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0001
Target:
CD47
Host Species:
Chimeric Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
Hu5F9-G4
Description:
Anti-CD47 (magrolimab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
